Skip to main content
. 2019 Oct 29;21:221. doi: 10.1186/s13075-019-2012-x

Fig. 1.

Fig. 1

Numbers of axSpA patients, who were screened, included in the study and included in the analyses. Flow chart template modified from http://consort-statement.org. PROMS, patient-reported outcome measurements; F-calprotectin, fecal calprotectin; P-Calprotectin, plasma calprotectin. 1Did not fulfill the axSpA classification criteria, 2The Medical Outcomes Study SF-36 questionnaire is missing